To verify these observations at the protein level, we determined FoxM1 expression using a tissue microarray (TMA) constructed in our laboratory, which harbors 13 astrocytomas (grade II), 25 anaplastic astrocytomas (grade III) and 80 GBM (grade IV) specimens. The gene discussed is FOXM1; the disease is astrocytoma (excluding glioblastoma).